Detalhe da pesquisa
1.
Characterization and comparison of innate and adaptive immune responses at vaccine sites in melanoma vaccine clinical trials.
Cancer Immunol Immunother
; 70(8): 2151-2164, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33454795
2.
The Barrier Molecules Junction Plakoglobin, Filaggrin, and Dystonin Play Roles in Melanoma Growth and Angiogenesis.
Ann Surg
; 270(4): 712-722, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31425296
3.
MDM2/MDMX inhibition by Sulanemadlin synergizes with anti-Programmed Death 1 immunotherapy in wild-type p53 tumors.
iScience
; 27(6): 109862, 2024 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38784022
4.
Barriers to immune cell infiltration in tumors.
J Immunother Cancer
; 11(4)2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37072352
5.
Peptide emulsions in incomplete Freund's adjuvant create effective nurseries promoting egress of systemic CD4+ and CD8+ T cells for immunotherapy of cancer.
J Immunother Cancer
; 10(9)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36939214
6.
NK cells reduce anergic T cell development in early-stage tumors by promoting myeloid cell maturation.
Front Oncol
; 12: 1058894, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36531040
7.
Differential Expression of CD49a and CD49b Determines Localization and Function of Tumor-Infiltrating CD8+ T Cells.
Cancer Immunol Res
; 9(5): 583-597, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33619119
8.
Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts.
Cell Rep
; 36(3): 109422, 2021 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289373
9.
Incomplete Freund's adjuvant reduces arginase and enhances Th1 dominance, TLR signaling and CD40 ligand expression in the vaccine site microenvironment.
J Immunother Cancer
; 8(1)2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32350119
10.
Vaccine Strategy in Melanoma.
Surg Oncol Clin N Am
; 28(3): 337-351, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31079792
11.
A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients.
J Immunother Cancer
; 7(1): 163, 2019 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31248461
12.
Formation and phenotypic characterization of CD49a, CD49b and CD103 expressing CD8 T cell populations in human metastatic melanoma.
Oncoimmunology
; 7(10): e1490855, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30288359